Isotope therapy

The 2022 list of medical technologies approved for innovation funding (NUB) released in Germany

14

Feb 2022

On January 28, 2022, the Institute for the Hospital Remuneration System (InEK) has published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2021. The medical technologies belonging to the cardiovascular, ENT, eHealth, gastrointestinal, neuromodulation, neurovascular, orthopedic, and other technology groups obtained positive status 1. Read more
The Norwegian Institute of Public Health (NIPH) has published a health technology assessment of 177Lutetium-based peptide receptor radionuclide therapy for treating neuroendocrine tumors

06

Jul 2018

Norwegian Institute of Public Health (NIPH) conducted a full health technology assessment (HTA) of Peptide receptor radionuclide therapy (PRRT) using 177Luthetium (177Lu-PRRT) on the request from payers (“New methods” framework for introduction of innovations in Norway). Read more